RE:RE:20% of all Global Deaths ?There is lots to think about...
...including an extrapolation that if only 5 % of the world's Sepsis patients were tested with just one EAA at $ 200
The resulting annual revenue generated would be:
50,000,000 sepsis patients annually x $ 200 x 5% = $ 500 Million high margin USD !
And if just 10% worldwide penetration of EAA in ICU's, at an average of 2 tests per (remembering that the typical PMX treated patient will likely go through 5 more more EAA's as a companiion diagnostic - before, during and after treatment with PMX)
Then the resulting revenue from EAA would be...
a staggering 50,000,000 x $ 200 X 2 x 10% = $ 2 Billion high margin USD !
MM
PS check my math...and have some fun with calculations of an average of 3-4 tests per patient, or 25 to 35 % market penetration worldwide.
And remember that the EAA should be used as a triage tool (IMHO). To determine whether a patient presenting with Sepsis-like symptoms, even has Sepsis in teh first place.